| abstract |
The present invention relates to a pharmaceutical composition for the treatment of liver cancer comprising a nanostructure on which an anticancer drug is supported. More specifically, the present invention relates to a pharmaceutical composition for treating liver cancer, comprising a nanostructure carrying an anticancer drug on a polymer (pPBA) formed by coupling phenylboronic acid to a maleic anhydride polymer, To a pharmaceutical composition for the treatment of liver cancer. The nanostructure of the present invention is excellent in tumor growth inhibition effect in cancer, particularly in liver cancer, excellent in drug delivery effect to a tumor site, and can specifically function as a tumor marker because it binds specifically to cancer cells, Since it is metabolized, it is expected to be widely used in the medical field. |